Meirui An

1.4k citations
6 papers · 883 indexed · 4 hit papers · h-index 5

Impact in

Papers in

    • Virus-based gene therapy research 4
    • CRISPR and Genetic Engineering 6
    • RNA and protein synthesis mechanisms 1
    • Advanced biosensing and bioanalysis techniques 1

Meirui An

6 papers receiving 866 citations

Hit Papers

Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo 2024 · 128 citations
1282021202620222024100200300400

Peers

Meirui An
Comparison fields: 5 of 57
  • Business and International Management 64
  • Aging 46
  • Molecular Biology 824
  • Genetics 255
  • Plant Science 88
Replace Alvin Hsu with:
Alvin Hsu United States
Purnima Ravisankar United States
Kelcee A. Everette United States
Beverly Mok United States
Jason Potter United States
Tanglong Yuan China
Zhiquan Liu China
Do Yon Kim South Korea
Su Bin Moon South Korea
Ravi Alla United States
Meirui An relative to Alvin Hsu United States Alvin Hsu's profile →
Citations per field
00.5×3.5×
Alvin Hsu · 1×
Citations per year

Countries citing papers authored by Meirui An

Since Specialization
Citations

This map shows the geographic impact of Meirui An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meirui An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meirui An more than expected).

Fields of papers citing papers by Meirui An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meirui An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meirui An. The network helps show where Meirui An may publish in the future.

Co-authors

The 25 scholars most cited alongside Meirui An, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Meirui An Line = papers co-authored together Meirui An links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1 20251
2
Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo
Hit paper breakdown →
2024128
3 202416
4
Efficient prime editing in mouse brain, liver and heart with dual AAVs
Hit paper breakdown →
2023114
5
Phage-assisted evolution and protein engineering yield compact, efficient prime editors
Hit paper breakdown →
2023161
6
Engineered pegRNAs improve prime editing efficiency
Hit paper breakdown →
2021463

About Meirui An

Meirui An is a scholar working on Genetics, Molecular Biology, Cardiology and Cardiovascular Medicine, Ecology and Public Health, Environmental and Occupational Health, having authored 6 papers that have together received 883 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (6 papers), Virus-based gene therapy research (4 papers), Viral Infections and Immunology Research (1 paper), Bacteriophages and microbial interactions (1 paper), Cytomegalovirus and herpesvirus research (1 paper), RNA and protein synthesis mechanisms (1 paper), Advanced biosensing and bioanalysis techniques (1 paper) and Mosquito-borne diseases and control (1 paper). The work is most often cited by research in Business and International Management (64 citations), Aging (46 citations), Molecular Biology (824 citations), Genetics (255 citations) and Plant Science (88 citations). Meirui An has collaborated with scholars based in United States. Frequent co-authors include Gregory A. Newby, Peyton B. Randolph, Kelcee A. Everette, Andrew V. Anzalone, Peter J. Chen, Alvin Hsu, Simon P. Shen, James W. Nelson, David Liu and Jonathan C. Chen. Their work appears in journals such as Nature Biotechnology, Nature and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026